Brian S. Cummings
Affiliations: | Pharmaceutical and Biomedical Sciences | University of Georgia, Athens, Athens, GA, United States |
Google:
"Brian Cummings"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mitra Ghosh T, White J, Davis J, et al. (2021) Identification and Characterization of Key Differentially Expressed Genes Associated With Metronomic Dosing of Topotecan in Human Prostate Cancer. Frontiers in Pharmacology. 12: 736951 |
| Kaur SP, Verma A, Lee HK, et al. (2021) Inhibition of glypican-1 expression induces an activated fibroblast phenotype in a human bone marrow-derived stromal cell-line. Scientific Reports. 11: 9262 |
| Najahi-Missaoui W, Arnold RD, Cummings BS. (2020) Safe Nanoparticles: Are We There Yet? International Journal of Molecular Sciences. 22 |
| Najahi-Missaoui W, Quach ND, Somanath PR, et al. (2020) Liposomes Targeting P21 Activated Kinase-1 (PAK-1) and Selective for Secretory Phospholipase A (sPLA) Decrease Cell Viability and Induce Apoptosis in Metastatic Triple-Negative Breast Cancer Cells. International Journal of Molecular Sciences. 21 |
| Verma A, Najahi-Missaoui W, Cummings BS, et al. (2020) Sterically stabilized liposomes targeting P21 (RAC1) activated kinase-1 and secreted phospholipase A suppress prostate cancer growth and metastasis. Oncology Letters. 20: 179 |
| Verma A, Artham S, Alwhaibi A, et al. (2020) PAK1 inhibitor IPA-3 mitigates metastatic prostate cancer-induced bone remodeling. Biochemical Pharmacology. 177: 113943 |
| Finnerty MC, Ingram LM, Mansoura M, et al. (2020) Lipidomic Analysis Demonstrates that 36:1 Phosphatidylcholine is Enriched in Cell Models of Drug Resistance Prostate Cancer The Faseb Journal. 34: 1-1 |
| Alnaim AS, Arnold R, Eggert M, et al. (2020) Role of PLA2R1 and sPLA2 on Drug Release and Uptake of Liposome Nanoparticles in Prostate Cancer The Faseb Journal. 34: 1-1 |
| Najahi-Missaoui W, Quach ND, Jenkins A, et al. (2019) Effect of P21-activated kinase 1 (PAK-1) inhibition on cancer cell growth, migration, and invasion. Pharmacology Research & Perspectives. 7: e00518 |
| Quach ND, Kaur SP, Eggert MW, et al. (2019) Paradoxical Role of Glypican-1 in Prostate Cancer Cell and Tumor Growth. Scientific Reports. 9: 11478 |